CANCER diagnostics company Biolidics is expecting "strong interest" for its share placement that could raise some S$3.1 million to fuel its business expansion and pursue new growth opportunities.
"While the current market conditions are choppy, we are encouraged that...
Register to read this article. Log in if you are already a subscriber.Register to read this article. Log in if you are already a subscriber.Please log in or subscribe to continue reading.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes